$78.67
0.740.95%
Last update: Nov 11, 7:13 AM
BridgeBio Pharma Inc (BBIO) Stock Price, Quote, News & History
BBIONASDAQ
BridgeBio Pharma (NASDAQ:BBIO) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.
Other companies in BridgeBio Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
BridgeBio Pharma has a consensus price target of $93.64.
The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $79.01 last updated November 11, 2026 at 7:13 AM EST.
There are no upcoming dividends for BridgeBio Pharma.
BridgeBio Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for BridgeBio Pharma.
BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian...
